发明名称 Formulation of drugs and vaccines in the form of percutaneous injectable needles
摘要 The invention relates to percutaneous administration of drugs and vaccines in form of solid penetrating needles, “injectable needles”, comprising a polymeric matrix resulting from the polymerization of a polymerizable paste or mixture. The injectable needles are hard enough to penetrate the skin and can be administered percutaneously by simple pusher or injector delivery devices. The manufacturing procedure of the injectable needles allows for the incorporation of the drug as preformulated stable microparticles and incorporation of modifying agents to modulate stiffness, solubility and drug release. Drugs formulated in these injectable needles offer a safe, simple and effective alternative to conventional percutaneous drug delivery systems based on hypodermic needles and syringes that require refrigerated storage and reconstitution prior to administration.
申请公布号 US9271927(B2) 申请公布日期 2016.03.01
申请号 US201013500279 申请日期 2010.10.08
申请人 AZUREBIO, S.L. 发明人 García De Castro Andrews Arcadio;García Carrodeaguas Raúl;Acosta Contreras Niuris
分类号 A61K39/29;A61K38/16;A61K38/38;A61K38/47;A61K9/00;A61K41/00;A61M37/00;A61K39/12;A61K9/16;A61K39/00;C08F220/06;C08F220/56;C08F220/58;C08F222/10;C08F222/32 主分类号 A61K39/29
代理机构 Blank Rome LLP 代理人 Blank Rome LLP
主权项 1. An injectable needle, with a diameter ranging from 0.2 to 2 mm, comprising: a) 30% to 90% in mass of a solid polymeric matrix continuous phase having a flexural strength over 10 MPa and comprising (i) an addition polymer formed by the polymerization of addition monomers, wherein the addition polymer is selected from the group consisting of polycyanoacrylates, polyacrylates, polymethacrylates, polyvinyls, and any combination thereof, and (ii) a polymeric modifying agent selected from the group consisting of polylactides, polyglycolides, polylactide-co-glycolides or polyvinylpyrrolidones, and any combination thereof, wherein the polymeric matrix is at least partially biodegradable or resorbable, and b) a solid discontinuous water-soluble phase containing a drug preformulated as particles or granules having a diameter between about 0.02 and about 500 microns, the solid discontinuous water-soluble phase in direct contact with the solid polymeric matrix, wherein the injectable needle is formed within a mold by polymerization of the addition monomers in the presence of the polymeric modifying agent to form an interpenetrating polymeric network (IPN) that incorporates the solid discontinuous water-soluble phase.
地址 Madird ES